These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9728229)

  • 21. Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia?
    Halpern MT; Cifaldi MA
    Clin Infect Dis; 2004 Jul; 39(1):144-5; author reply 145-6. PubMed ID: 15206068
    [No Abstract]   [Full Text] [Related]  

  • 22. Community-acquired pneumonia guidelines: Peering back through the looking glass...clearly?
    Peterson MW; Hornick DB
    Am J Med; 2004 Nov; 117(10):799-800. PubMed ID: 15541330
    [No Abstract]   [Full Text] [Related]  

  • 23. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.
    Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ
    Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.
    Feldman RB; Rhew DC; Wong JY; Charles RA; Goetz MB;
    Arch Intern Med; 2003 Jul; 163(14):1718-26. PubMed ID: 12885688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time to first antibiotic and mortality in adults hospitalised with community-acquired pneumonia: a matched-propensity analysis.
    Daniel P; Rodrigo C; Mckeever TM; Woodhead M; Welham S; Lim WS;
    Thorax; 2016 Jun; 71(6):568-70. PubMed ID: 26559161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time to antibiotics administration and outcome in community-acquired pneumonia: Secondary analysis of a randomized controlled trial.
    Marti C; John G; Genné D; Prendki V; Rutschmann OT; Stirnemann J; Garin N
    Eur J Intern Med; 2017 Sep; 43():58-61. PubMed ID: 28648477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [When does pneumonia belong in the hospital -- and when not. Community-acquired -- healed by ambulatory care?].
    MMW Fortschr Med; 2003 Mar; 145(10):12-3. PubMed ID: 12688019
    [No Abstract]   [Full Text] [Related]  

  • 28. [Management of community acquired pneumonia in adults following clinical guidelines at a rural hospital].
    Sanhueza A LM; Vásquez P C; Sepúlveda Z F; Barahona C F; González C R; Saldías P F
    Rev Med Chil; 2009 Oct; 137(10):1283-90. PubMed ID: 20011934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical policy: critical issues in the management of adult patients presenting to the emergency department with community-acquired pneumonia.
    Nazarian DJ; Eddy OL; Lukens TW; Weingart SD; Decker WW
    Ann Emerg Med; 2009 Nov; 54(5):704-31. PubMed ID: 19853781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy for severe community-acquired pneumonia.
    Berk SL
    Clin Infect Dis; 1997 Jul; 25(1):168-9. PubMed ID: 9243063
    [No Abstract]   [Full Text] [Related]  

  • 31. Atypical coverage in community-acquired pneumonia after outpatient beta-lactam monotherapy.
    van Werkhoven CH; van de Garde EMW; Oosterheert JJ; Postma DF; Bonten MJM
    Respir Med; 2017 Aug; 129():145-151. PubMed ID: 28732822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A teaching hospital's experience applying the Pneumonia Severity Index and antibiotic guidelines in the management of community-acquired pneumonia.
    Lee RW; Lindstrom ST
    Respirology; 2007 Sep; 12(5):754-8. PubMed ID: 17875067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of indicators to evaluate the quality of community-acquired pneumonia management.
    Nathwani D; Williams F; Winter J; Winter J; Ogston S; Davey P
    Clin Infect Dis; 2002 Feb; 34(3):318-23. PubMed ID: 11774078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of ertapenem for the treatment of community-acquired pneumonia in routine hospital practice: a matched cohort study.
    Sousa D; Bravo-Ferrer JM; Seoane-Pillado T; Vázquez-Rodríguez P; Ramos-Merino L; Gutiérrez-Urbón JM; Pita S; Llinares P
    Rev Esp Quimioter; 2016 Oct; 29(5):259-64. PubMed ID: 27608182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicted effects on antibiotic use following the introduction of British or North American guidelines for community-acquired pneumonia in The Netherlands.
    Oosterheert JJ; Bonten MJ; Schneider MM; Hoepelman IM
    Clin Microbiol Infect; 2005 Dec; 11(12):992-8. PubMed ID: 16307553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited value of routine microbiological diagnostics in patients hospitalized for community-acquired pneumonia.
    Lidman C; Burman LG; Lagergren A; Ortqvist A
    Scand J Infect Dis; 2002; 34(12):873-9. PubMed ID: 12587618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis.
    Heo JY; Seo YB; Choi WS; Lee J; Yoon JG; Lee SN; Choi MJ; Noh JY; Ahn JY; Jeong HW; Cheong HJ; Kim WJ; Lee HY; Song JY
    PLoS One; 2018; 13(3):e0194598. PubMed ID: 29596444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythromycin compared with a combination of ampicillin plus flucloxacillin for the treatment of community acquired pneumonia in adults.
    Shanson DC; McNabb WR; Williams TD; Lant AF
    J Antimicrob Chemother; 1984 Jul; 14(1):75-9. PubMed ID: 6480543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience with levofloxacin in a critical pathway for the treatment of community-acquired pneumonia.
    Marrie TJ
    Chemotherapy; 2004; 50 Suppl 1():11-5. PubMed ID: 15319549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.
    Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
    BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.